REG - AIM - AIM Notice - 22/01/2026

Medpal AIAnnouncement

Today 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260122:nRSV8406Pa&default-theme=true

RNS Number : 8406P  AIM  22 January 2026

NOTICE

 

22/01/2026 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 Andrada Mining Limited
 59,358,907  ORDINARY SHARES OF NO PAR VALUE FULLY PAID  (BD95V14)(GG00BD95V148)

 

 Intercede Group Plc
 200,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0328724)(GB0003287249)

 

 MedPal AI plc
 6,200,000  ORDINARY SHARES OF 0.02P EACH, FULLY PAID  (BTRC7N3)(GB00BTRC7N37)

 

 Onward Opportunities Limited
 541,079  ORDINARY SHARES OF NO PAR VALUE EACH, FULLY PAID  (BMZR151)(GG00BMZR1514)

 

 Pantheon Resources PLC
 106,209,678  ORDINARY SHARES OF 1P EACH, FULLY PAID  (B125SX8)(GB00B125SX82)

 

 SkinBioTherapeutics plc
 129,736  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BF33H87)(GB00BF33H870)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBLGDBDDDDGLB



            Copyright 2019 Regulatory News Service, all rights reserved